Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat. - Wikidata - awgldk - TriplyDB

Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat.

Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat.

http://www.wikidata.org/entity/Q33268794

about

Chemotherapy-induced peripheral neuropathy: an update on the current understanding Chemotherapy-induced peripheral neurotoxicity: a critical analysis Animal models of peripheral neuropathies Dysferlin-peptides reallocate mutated dysferlin thereby restoring function Synergistic apoptosis induction in leukemic cells by the phosphatase inhibitor salubrinal and proteasome inhibitors The proteasome inhibitor bortezomib enhances ATRA-induced differentiation of neuroblastoma cells via the JNK mitogen-activated protein kinase pathway Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse Peripheral neuropathy outcomes and efficacy of subcutaneous bortezomib when combined with thalidomide and dexamethasone in the treatment of multiple myeloma.Accumulation of misfolded SOD1 in dorsal root ganglion degenerating proprioceptive sensory neurons of transgenic mice with amyotrophic lateral sclerosis Bortezomib treatment produces nocifensive behavior and changes in the expression of TRPV1, CGRP, and substance P in the rat DRG, spinal cord, and sciatic nerve.Peripheral neuropathy and new treatments for multiple myeloma: background and practical recommendations.Dorsal Column Degeneration after Bortezomib Therapy in a Patient with Multiple Myeloma.Acetyl-L-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the Wisconsin Oncology The treatment of traumatic brain injury with velcade.Proteasome inhibition and its therapeutic potential in multiple myeloma Schwann cell autophagy induced by SAHA, 17-AAG, or clonazepam can reduce bortezomib-induced peripheral neuropathy Complete atrioventricular block secondary to bortezomib use in multiple myeloma.Proteasome inhibitors in the treatment of multiple myeloma Bortezomib, a proteasome inhibitor, attenuates angiotensin II-induced hypertension and aortic remodeling in rats.Platinum-induced neurotoxicity and preventive strategies: past, present, and future Acupuncture treatment for bortezomib-induced peripheral neuropathy: a case report Genetic factors underlying the risk of bortezomib induced peripheral neuropathy in multiple myeloma patients.CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats.Arsenic trioxide rewires mantle cell lymphoma response to bortezomib White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.Proteasome Inhibition After Burn Injury Neurotoxicity to DRG neurons varies between rodent strains treated with cisplatin and bortezomib.Nerve growth factor alters microtubule targeting agent-induced neurotransmitter release but not MTA-induced neurite retraction in sensory neurons.Subclinical pretreatment sensory deficits appear to predict the development of pain and numbness in patients with multiple myeloma undergoing chemotherapy.The protective effects of lafutidine for bortezomib induced peripheral neuropathy.Can medical herbs stimulate regeneration or neuroprotection and treat neuropathic pain in chemotherapy-induced peripheral neuropathy?Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN).Peripheral neuropathy during bortezomib treatment of multiple myeloma: a review of recent studies.Chemotherapy-induced peripheral neuropathies: from clinical relevance to preclinical evidence.Proteasome inhibitors in multiple myeloma: 10 years later.Inhibitors for the immuno- and constitutive proteasome: current and future trends in drug development.A case of peripheral nerve microvasculitis associated with multiple myeloma and bortezomib treatment.Rodent models of chemotherapy-induced peripheral neuropathy.Bortezomib-induced peripheral neurotoxicity: an update.Chemotherapy-induced peripheral neuropathies in hematological malignancies.

P2860

Q26740689-140A2A5B-EBCB-4C9A-B504-5AA0712E5C00 Q27010318-69D903A3-A3F2-48D4-B6A8-057323B91D03 Q27028046-AB3D22E3-3446-4686-BFAB-681AF6F33E7B Q27335454-09672966-C25D-4A5E-95E0-E446E5D611BD Q28474489-C2B01F97-FA63-4677-8101-0D33D9DB4582 Q28477838-A8D01F88-FD09-4DDF-A896-38AEAD2FE2CB Q28533426-3D99D56C-D360-40C4-9204-68EBD8494DFC Q33437045-025F1941-DB01-4C38-B650-81A8474F5A1C Q33616950-BAD421C3-D298-4080-86A4-B3C506FDA178 Q33617012-8DFC6F2E-403B-41F6-B8D4-EC2577768B8C Q33632270-F7A52AE1-305E-43AE-95EE-9904402771EF Q34038037-68FF92FF-CCF5-4206-8375-1A19DB842945 Q34245549-514EB2E9-634C-4446-A6AD-FF178ED97963 Q34254813-A799160A-D80A-4398-A498-0E4CDB883C11 Q34343036-FC903120-AEB7-4575-8A43-0DCEAB624024 Q34344053-6E7B417B-E35D-4AB2-AAC6-E6B989D6A3E0 Q34474586-32AA5DE2-D798-404D-9933-FEE4F4A73512 Q34611676-30A8EAA5-2B13-414A-A79D-2CEDD6B91676 Q35036537-25350C6D-235F-456D-8569-F40D2645D0D3 Q35345734-1C0D2A38-55C1-4521-8C0D-CA52E1C3F7EF Q35428713-5B85A1C5-9E75-443E-B3D0-FD84680906CC Q35528750-C2395758-0C0A-4908-9FC4-81E99889C865 Q36084704-A3FEBA66-062A-49C0-A79E-CA607A37C88D Q36358595-A23879F1-AD6D-48C9-9B48-8E1FAC0A1845 Q36437623-52E543C0-1FC1-4C2C-A703-F52B8E3BFB9B Q36487994-7311432C-7E20-415F-9F8D-7CA27F95BDB9 Q36655166-42C10977-1E4B-495F-9F13-6AF94C75D22D Q36884527-0D591351-9A52-499F-9C93-9A494270F551 Q36893299-B09BF448-77B5-4B77-A88B-3C10EA50976B Q37017164-3901E72A-B714-4AD9-9564-3832AA9AC0BC Q37105226-560A7BF4-341C-4106-B780-9542E451E705 Q37399781-BA1638C2-F0A8-4C03-ACAD-3E5FC6303926 Q37760210-F9B59A2C-EFA8-4024-BE1C-FABC90E74AAF Q37826427-0A7BA4C2-62F5-42DD-9D7D-43E6B5E6453F Q38014395-59270136-9FC9-4B86-87F0-F9BDAF7F2A4E Q38019864-93A56B92-7F8B-4057-AC9A-B0EA4A38C1EE Q38066137-C83DCD79-B477-416B-B23D-F3FF345D62E5 Q38194947-85811ED9-3A64-4BD5-8F83-0C467E2EFE6C Q38234733-D2423858-B609-4DD4-8661-6282B3985464 Q38261204-8399068C-93D3-4A2C-8B81-0AD7D56ADD84

P2860

Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat.

http://www.wikidata.org/entity/Q33268794

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Bortezomib-induced peripheral ...... pathological study in the rat.

@ast

Bortezomib-induced peripheral ...... pathological study in the rat.

@en

Bortezomib-induced peripheral ...... pathological study in the rat.

@nl

type

label

Bortezomib-induced peripheral ...... pathological study in the rat.

@ast

Bortezomib-induced peripheral ...... pathological study in the rat.

@en

Bortezomib-induced peripheral ...... pathological study in the rat.

@nl

prefLabel

Bortezomib-induced peripheral ...... pathological study in the rat.

@ast

Bortezomib-induced peripheral ...... pathological study in the rat.

@en

Bortezomib-induced peripheral ...... pathological study in the rat.

@nl

P1433

Q33268794-4A7B203E-436C-4230-AD96-8AB64AD19365

P1476

Q33268794-F397D032-E685-4D7D-9190-40928298155E

P2093

Q33268794-03C0B76B-F50D-48C8-8404-8A6F6E59354F

Q33268794-12A95CAB-6F4A-46E7-82B3-B70A9740B456

Q33268794-3DF8036B-DCA8-493C-975C-53BCBB3980B3

Q33268794-49E8F527-AA97-460E-930E-4FFF8ED48EE9

Q33268794-9855C99D-7708-4FEA-844B-9AA290B9A28A

Q33268794-A77EA0D7-D102-4B4D-9866-3EF8C93FE142

Q33268794-A7FC6836-28AA-4441-8D52-3AC43F9406D2

Q33268794-B15E2D00-BDF3-4A2E-8274-9EA93BFCEB91

Q33268794-DF66CBE5-C484-4CC4-A2E6-2D7134473D32

P304

Q33268794-C508310A-9BFC-4CDA-BDC6-A70EEAF3318C

P31

Q33268794-344846FE-C47B-4F5A-ACFF-778E381F7E1D

P356

Q33268794-E4DD77F7-3FB0-4798-BF0B-5B430D094AB9

P407

Q33268794-7FDC8F39-F0C4-48E8-A7C0-637DB2F4D73A

P433

Q33268794-747EB3B9-0A16-4A11-A660-4D90B12952F7

P478

Q33268794-F57C4CA8-FBC8-41B0-A711-68C4BB8655F7

P50

Q33268794-851B7383-F1ED-4D84-9371-4031665D76C4

Q33268794-B15EA7B2-983E-423A-A0E3-8F5BB64C3D4D

P577

Q33268794-9753B6FB-B375-44D5-803D-C163294AB880

P698

Q33268794-AE7CEC4B-06F2-447F-92A4-20280AFDA4A6

P921

Q33268794-1AB92C73-8613-45DA-98B1-8F96E3672C83

Q33268794-2E5E116F-ED00-4FBD-82A9-F8CE5099B05D

P356

J.EXPNEUROL.2006.11.010

P1433

Experimental Neurology

P1476

Bortezomib-induced peripheral ...... pathological study in the rat.

@en

P2093

Alessandra Gilardini

http://www.w3.org/2001/XMLSchema#string

Annalisa Canta

http://www.w3.org/2001/XMLSchema#string

Cecilia Ceresa

http://www.w3.org/2001/XMLSchema#string

Laura Rigamonti

http://www.w3.org/2001/XMLSchema#string

Mario Bossi

http://www.w3.org/2001/XMLSchema#string

Norberto Oggioni

http://www.w3.org/2001/XMLSchema#string

Paola Marmiroli

http://www.w3.org/2001/XMLSchema#string

Roland De Coster

http://www.w3.org/2001/XMLSchema#string

Virginia Rodriguez-Menendez

http://www.w3.org/2001/XMLSchema#string

P304

317-325

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EXPNEUROL.2006.11.010

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

204

http://www.w3.org/2001/XMLSchema#string

P50

Maurizio D'Incalci

Guido Cavaletti

P577

2007-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17214983

http://www.w3.org/2001/XMLSchema#string

P921

neurophysiology